scholarly article | Q13442814 |
P2093 | author name string | Frasier SD | |
P433 | issue | 6 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 929-937 | |
P577 | publication date | 1974-06-01 | |
P1433 | published in | Pediatrics | Q7159238 |
P1476 | title | A preview of growth hormone stimulation tests in children | |
P478 | volume | 53 |
Q49044648 | A new test for the diagnosis of growth hormone deficiency due to primary pituitary impairment: combined administration of pyridostigmine and growth hormone-releasing hormone |
Q42128204 | An approach to solving problems of growth retardation in the child and teenager |
Q72301360 | Circulating immunoreactive growth hormone releasing hormone concentrations and growth hormone response to growth hormone releasing hormone in short children |
Q34986196 | Combined test of anterior pituitary function in children |
Q70542433 | Diagnosis and treatment of short stature |
Q37075275 | Diagnosis of GH deficiency: auxologic and GH response criteria |
Q72166707 | Diagnosis of growth hormone deficiency |
Q72564443 | Evaluation of growth hormone in thalassaemic boys with failed puberty: spontaneous versus provocative test |
Q69807144 | Evidence of polyglandular involvement in Niemann-Pick disease type B |
Q38287322 | Glucagon administration elicits blunted GH but exaggerated ACTH response in obesity |
Q60674318 | Glucagon is an ACTH secretagogue as effective as hCRH after intramuscolar administration while it is ineffective when given intravenously in normal subjects |
Q41375529 | Growth hormone cotreatment with gonadotropins in ovulation induction |
Q71164179 | Growth hormone deficiency and growth hormone therapy in Ullrich-Turner-syndrome |
Q58329884 | Growth hormone secretion in empty sella syndrome |
Q34381507 | Growth hormone-releasing hormone combined with arginine or growth hormone secretagogues for the diagnosis of growth hormone deficiency in adults |
Q40192812 | Human growth hormone deficiency |
Q48686386 | Is the persistence of isolated GH deficiency in adulthood predicted by anatomical hypothalamic-pituitary alterations? |
Q50570622 | Longitudinal relationship between insulin-like growth factor-1 levels and vertical facial growth. |
Q60674361 | Low dose orally administered arginine is able to enhance both basal and growth hormone-releasing hormone-induced growth hormone secretion in normal short children |
Q35957854 | Medical Research Council of Canada therapeutic trial of human growth hormone: first 5 years of therapy |
Q43010852 | More guidance on growth hormone deficiency |
Q34494398 | Nocturnal growth hormone and gonadotrophin secretion in growth retarded children with Crohn's disease |
Q66923413 | Pattern of growth hormone response to insulin, arginine and haemodialysis in uraemic children |
Q70175628 | Premarin priming does not alter growth hormone release following exercise |
Q73759323 | Sequential administration of arginine and arginine plus GHRH to test somatotroph function in short children |
Q36283893 | Short Stature in Childhood and Adolescence: Part 1: Medical management |
Q44077753 | Short procedure of GHRH plus arginine test in clinical practice |
Q35116365 | Sleep-induced growth hormone release--evaluation of a simple test for clinical use. |
Q35683909 | Somatotropin in the treatment of growth hormone deficiency and Turner syndrome in pediatric patients: a review |
Q48987026 | Testing with growth hormone-releasing factor (GRF(1-29)NH2) and somatomedin C measurements for the evaluation of growth hormone deficiency |
Q57826887 | The Wingate anaerobic test cannot be used for the evaluation of growth hormone secretion in children with short stature |
Q34538898 | Therapeutic use of human growth hormone |
Q46685754 | Unreliability of classic provocative tests for the diagnosis of growth hormone deficiency. |
Search more.